References
- Haga Y., Yanagi H., Urata J. et al. Early detection of pancreatic glucagonoma. Am J Gastroenterol, 1995, 90: 2216–23.
- Chastain M. A. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci, 2001, 321: 306–20.
- Tomassetti P., Migliori M., Lalli S., Campana D., Tomassetti V., Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic andocrine tumours. Ann Oncol, 2001, 12: s95–9.
- Owen N. J., Sohaib S. A., Peppercorn P. D. et al. MRI of pancreatic neuroendocrine tumours. Br J Radiol, 2001, 74: 968–73.
- Anderson M. A., Carpenter S., Thompson N. W., Nostrant T. T., Elta G. H., Scheiman J. M. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol, 2000, 95: 2271–7.
- Bombardieri E., Maccauro M., De Deckere E., Savelli G., Chiti A. Nuclear medicine imaging of neuroendocrine tumours. Ann Oncol, 2001, 12: S51–61.
- Chiti A., Briganti V., Fanti S., Monetti N., Masi R., Bombardieri E. Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours. Q J Nucl Med, 2000, 44: 42–9.
- Udelsman R., Yeo C. J., Hruban R. H. et al. Pancreatico-duodenectomy for selected pancreatic endocrine tumors. Surg Gynecol Obstet, 1993, 177: 269–78.
- Brentjens R., Saltz L. Islet cell tumors of the pancreas: the medical oncologist’s perspective.Surg Clin North Am, 2001, 81: 52742.
- Azimuddin K., Chamberlain R. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am, 2001, 81: 511–25.
- Hunt S., Narus V., Abell E. Necrolytic migratory erythema: dys-keratotic dermatitis, a clue to early diagnosis. J Am Acad Dermatol, 1991, 24: 473–7.